Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 million to buy shares.
Continue Reading
View Comments
Vertex Pharma CEO Buys the Stock Dip
Published 2 months ago
Aug 15, 2025 at 9:52 PM
Neutral
Auto